Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China

Abstract

In the present study, we aimed at exploring the applied value of preoperative neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) in the prediction of lymph node metastasis (LNM) and prognosis in patients with early gastric cancer (EGC). We retrospectively analyzed a total of248 consecutive patients who underwent curative gastrectomy to be identified T1 stage gastric adenocarcinoma between January 1, 2010 and May 1, 2016 in a single institution. According to median preoperative NLR and PLR value, we divided the patients into four groups: high NLR >1.73 and low NLR <1.73, high PLR >117.78 and low PLR <117.78. Furthermore, to evaluate the relationship between preoperative NLR and PLR values, we categorized patients according to cutoff preoperative NLR-PLR score of 2 [high NLR (>1.73) and high PLR (>117.78)], 1 [either high NLR or high PLR], and 0 [neither high NLR nor high PLR], Statistical analyses were conducted using SPSS 20.0 software. The results showed that the preoperative NLR or PLR values, lower or higher, could not predict the LNM in patients with EGC (both P=0.544>0.05). The invasive depth of tumor was significantly correlated with LNM of EGC (P0.001). Kaplan-Meier plots illustrated that preoperative NLR and PLR values were not associated with overall survival (OS) in patients with EGC. It was concluded that the preoperative NLR and PLR may be the predictors for LNM and prognosis in patients with advanced gastric cancer; nevertheless, they cannot predict LNM and prognosis in patients with EGC.

Keywords

early gastric cancer / neutrophil lymphocyte ratio / platelet lymphocyte ratio / lymph node metastasis / prognosis

References

[1] FerlayJ, SoeijomataramI, DikshitR, et al.. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5): E359-E386

[2] ShenL, ShanYS, HuHM, et al.. Management of gastric cancer in Asia: Resource-stratified guidelines. Lancet Oncol, 2013, 14(12): e535-547

[3] LeungWK, WuMS, KakugawaY, et al.. Screening for gastric cancer in Asia: Current evidence and practice. Lancet Oncol, 2008, 9(3): 279-287

[4] BittoniA, FaloppiL, GiampieriR, et al.. Selecting the best treatment for an individual patient. Recent Results Cancer Res, 2012, 196: 307-318

[5] WangW, LiYF, SunXW, et al.. Prognosis of 980 patients with gastric cancer after surgical resection. Chin J Cancer, 2010, 29(11): 923-930

[6] SasakoM, SakuramotoS, KataiH, et al.. Five year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-l versus surgery alone in stage II or III gastric cancer. J Clin Oncol, 2011, 29(33): 4387-4393

[7] Gastric Cancer, 2011, 14(2):

[8] GotoA, NishikawaJ, OkamotoT, et al.. Outcomes of endoscopic submucosal dissection for early gastric cancer and factors associated with incomplete resection. Hepatogastroenterology, 2013, 60: 46-53

[9] QianBZ, PollardJW. Macrophage diversity enhances tumor progression and metastasis. Cell, 2010, 141(1): 39-51

[10] McMillanDC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care, 2009, 12(3): 223-226

[11] SchreiberRD, OldLJ, SmythMJ. Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science, 2011, 331(6024): 1565-1570

[12] RaungkaewmaneeS, TangjitgamolS, ManusirivithayaS, et al.. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol, 2012, 23(4): 265-273

[13] J Natl Cancer Inst, 2014, 106(6):

[14] ShimadaH, TakiguchiN, KainumaO, et al.. High preoperative neutrophil lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer, 2010, 13(3): 170-176

[15] ZhangX, ZhangW, FengLJ, et al.. Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis. PLoS One, 2014, 9(11): el 11906

[16] IlhanN, IlhanY, AkbulutH, et al.. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol, 2004, 10(8): 1115-1120

[17] LianL, XiaYY, ZhouC, et al.. Application of platelet/ lymphocyte and neutrophil/ lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Cancer Biomark, 2015, 15(6): 899-907

[18] ZhouX, XuL, HuangZ, et al.. The hematologic markers as prognostic factors in patients with resectable gastric cancer. Cancer Biomark, 2016, 17(3): 359-367

[19] KimDK, OhSY, KwonHC, et al.. Clinical significances of preoperative seruminterleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer, 2009, 9: 155

[20] KilincalpS, EkizF, BasarO, et al.. Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets, 2014, 25(8): 592-594

[21] WalshSR, CookEJ, GoulderF, et al.. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol, 2005, 91(3): 181-184

[22] GwakMS, ChoiSJ, KimJA, et al.. Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer. J Korean Med Sci, 2007, 22: S104-108

[23] SmithRA, BosonnetL, RaratyM, et al.. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg, 2009, 197(4): 466-472

[24] SharaihaRZ, HalazunKJ, MirzaF, et al.. Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol, 2011, 18(12): 3362-3369

[25] ThavaramaraT, PhaloprakarnC, TangjitgamolS, et al.. Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. J Med Assoc Thai, 2011, 94(7): 871-877

[26] KemalY, YucelI, EkizK, et al.. Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis. Asian Pac J Cancer Prev, 2014, 15(6): 2651-2654

[27] AzabB, BhattVR, PhookanJ, et al.. Usefulness of the neutrophil-to-lymphocyte ratio in predicting shortand long-term mortality in breast cancer patients. Ann Surg Oncol, 2012, 19(1): 217-224

[28] ElinavE, NowarskiR, ThaissCA, et al.. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer, 2013, 13(11): 759-771

[29] J Biol-Chem, 2000, 275(3):

[30] BalkwillF, MantovaniA. Inflammation and cancer: back to Virchow?. Lancet, 2001, 357(9255): 539-545

[31] SicaA. Role of tumour-associated macrophages in cancer-related inflammation. Exp Oncol, 2010, 32(3): 153-158

[32] WangDS, LuoHY, QiuMZ, et al.. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol, 2012, 29(5): 3092-3100

[33] KarinM. Nuclear factor-kappaB in cancer development and progression. Nature, 2006, 441(7092): 43 M36

[34] GrivennikovSI, GretenFR, KarinM. Immunity, inflammation, and cancer. Cell, 2010, 140(6): 883-899

[35] OkabayashiT, KobayashiM, NishimoriI, et al.. Clinicopathological features and medical management of early gastric cancer. Am J Surg, 2008, 195(2): 229-232

[36] SkoropadV, BerdovB, ZagrebinV. Clinicopathological features and outcome of surgical treatment of 149 patients with early (pTl) gastric cancer. Onkologie, 2005, 28(5): 247-252

[37] YeBD, KimSG, LeeJY, et al.. Predictive factors for lymph node metastasis and endoscopic treatment strategies for undifferentiated early gastric cancer. J Gastroenterol Hepatol, 2008, 23(1): 46-50